In a landscape marked by innovation and progressive healthcare solutions, the Pelvic Reconstruction Industry is poised for substantial growth, with an average Compound Annual Growth Rate (CAGR) of 2.8% anticipated between 2023 and 2033. This projection positions the market to achieve a commendable market share of US$ 376.2 million by 2033, reflecting a significant leap from the estimated US$ 285.6 million value in 2023.
Furthermore, increasing awareness regarding vaginal health due to growing cases of pelvic disorders and deformities has surged the need for pelvic reconstruction products. On the back of this, key players are vying to develop systems that can be approved by regulatory authorities such as the FDA.
Additionally, growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is prompting the adoption of advanced systems for accurate and speedy recovery. There is also an increase in the research and development on handling pelvic floor disorders by mitigating the risk factors.
Get a Full PDF Sample Copy of the Latest Reports @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15500
Increasing use of tissue engineering to support pelvic floor and also promotes tissue repair. This is also highly biocompatible compared to the general approach of using polypropylene mesh. Hence, several ongoing research is focusing on tissue engineering such as the use of fibroblasts and stem cells is supporting the growth in pelvic reconstruction market.
Pelvic floor surgery refers to surgical procedures that are performed to rebuild or restore the structure and function of the pelvis. This type of surgery is typically needed in cases where the pelvic bones have been damaged or deformed due to trauma, disease, or congenital abnormalities.
Key Takeaways from Market Study
-
- Based on product type, vaginal sling systems held approximately 54.2% market value share in 2021, owing to rising cases of pelvic floor disorders.
- Surgical procedure is set to lead the market, in terms of procedures, and contributed around 78.9% of revenue in 2021.
- By indication, pelvic organ prolapse is expected to register growth at a CAGR of 2.7% during the forecast period.
- By pelvic organs, the vagina is the most affected organ and the segment held a share of about 38.6% in 2021.
- North America is considered as the leading region with a value share of 33.9% in 2021, owing to the high prevalence of pelvic floor disorders in the region.
“Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe,” says an analyst of Future Market Insights.
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15500
Market Competition
The market for pelvic reconstruction consists of a number of local as well as established players within the market sphere. There is increased research and development to meet the current needs of the population.
- In 2019, as per research conducted by Royal Hallamshire Hospital, UK, Ulrich et al. demonstrated that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
- Onkos Surgical declared in July 2022 that its My3D® Personalized Pelvic Reconstruction system had been granted 510(k) approval.
Key Companies Profiled:
- Johnson & Johnson Services, Inc.
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation (American Medical Systems Inc.)
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
- Cook Medical
- MEDGYN PRODUCTS, INC.
- CooperSurgical, Inc.
- DIMA S.L.
- Others
Click here today to buy your full report @ https://www.futuremarketinsights.com/checkout/15500
Key Market Segments Covered In Pelvic Reconstruction Industry Research
By Product:
- Vaginal Mesh
- Biological Mesh
- Synthetic Mesh
- Vaginal Sling Systems
- Vaginal Pessary
By Procedure:
- Non-Surgical
- Surgical
- Obliterative surgery
- Reconstructive surgery
- Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
- Colporrhalphy
- Sacrocolpopexy
- Sacrohysteropexy
- Transvaginal graft
- Sling Surgery
By Indication:
- Pelvic Organ Prolapse
- Vaginal Prolapse
- Rectal Prolapse
- Urinary Incontinence
- Interstitial Cystitis
- Fistulae
By Pelvic Organs:
- Uterus
- Ovaries
- Vagina
- Fallopian Tubes
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
